Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Petrobras Class A
PBR.A
$104B
| $4.51M | ﹤0.01% |
317,486
+151,713
| +92% | +$2.09M |
|
|
AIFU
3077
AIFU Inc
AIFU
$215M
| $4.51M | ﹤0.01% |
337
+316
| +1,505% | +$3.6M |
|
3078
CALL
Invesco
IVZ
$14.4B
| $4.51M | ﹤0.01% |
220,300
-143,800
| -39% | -$2.99M |
|
3079
AAR Corp
AIR
$5.85B
| $4.51M | ﹤0.01% |
122,511
-196,669
| -62% | -$6.51M |
|
|
CBIO
3080
Crescent Biopharma
CBIO
$637M
| $4.5M | ﹤0.01% |
3,780
-3,607
| -49% | -$4.31M |
|
3081
PUT
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.38B
| $4.5M | ﹤0.01% |
31,300
-10,800
| -26% | -$1.54M |
|
3082
CoreCivic
CXW
$3.25B
| $4.5M | ﹤0.01% |
216,601
-107,010
| -33% | -$2.3M |
|
3083
DHT Holdings
DHT
$3.15B
| $4.49M | ﹤0.01% |
759,706
+645,489
| +565% | +$3.52M |
|
|
OXFD
3084
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $4.49M | ﹤0.01% |
326,304
+238,001
| +270% | +$3.64M |
|
3085
CALL
State Street SPDR S&P Dividend ETF
SDY
$22.2B
| $4.49M | ﹤0.01% |
44,500
-4,000
| -8% | -$400K |
|
3086
CALL
Invesco CurrencyShares Canadian Dollar Trust
FXC
$73.9M
| $4.48M | ﹤0.01% |
59,500
+22,000
| +59% | +$1.62M |
|
3087
Anika Therapeutics
ANIK
$288M
| $4.48M | ﹤0.01% |
110,177
-50,082
| -31% | -$1.83M |
|
3088
Community Bank
CBU
$3.46B
| $4.48M | ﹤0.01% |
67,985
+2,334
| +4% | +$150K |
|
3089
Innoviva
INVA
$1.53B
| $4.47M | ﹤0.01% |
306,772
+5,060
| +2% | +$71.7K |
|
3090
PUT
AngloGold Ashanti
AU
$48.7B
| $4.46M | ﹤0.01% |
250,400
-2,000
| -0.8% | -$26.8K |
|
|
IIN
3091
DELISTED
IntriCon Corporation
IIN
| $4.46M | ﹤0.01% |
190,867
-113,696
| -37% | -$2.84M |
|
|
MNRL
3092
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $4.46M | ﹤0.01% |
+207,696
| New | +$4.31M |
|
3093
PUT
Alnylam Pharmaceuticals
ALNY
$30.6B
| $4.46M | ﹤0.01% |
61,400
+3,600
| +6% | +$276K |
|
3094
IPG Photonics
IPGP
$3.65B
| $4.45M | ﹤0.01% |
+28,867
| New | +$4.37M |
|
3095
Supernus Pharmaceuticals
SUPN
$2.81B
| $4.45M | ﹤0.01% |
134,555
-12,083
| -8% | -$414K |
|
3096
PUT
Box
BOX
$4.52B
| $4.45M | ﹤0.01% |
252,700
+81,100
| +47% | +$1.55M |
|
3097
Genesis Energy
GEL
$1.93B
| $4.45M | ﹤0.01% |
203,098
+172,391
| +561% | +$3.84M |
|
3098
iShares S&P 100 ETF
OEF
$20.5B
| $4.45M | ﹤0.01% |
34,321
+18,368
| +115% | +$2.35M |
|
|
CSFL
3099
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $4.45M | ﹤0.01% |
+193,075
| New | +$4.53M |
|
3100
First Financial Bancorp
FFBC
$3.61B
| $4.44M | ﹤0.01% |
183,501
+173,029
| +1,652% | +$4.16M |
|
Similar funds
Citadel Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Citadel Advisors held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Citadel Advisors's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Citadel Advisors added most to Netflix in Q2 2019, an estimated $400M increase.
- Citadel Advisors's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Citadel Advisors fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Citadel Advisors's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Citadel Advisors opened 1,217 new positions and closed 1,335 in Q2 2019.
- Citadel Advisors's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.